良性前列腺增生患者使用网络决策辅助工具前后的治疗偏好
本研究评估了提示良性前列腺增生(BPH)的下尿路症状(LUTS)患者在使用网络决策辅助工具(DA)前后的治疗偏好。2016年7月至2017年1月共纳入126例患者,结果显示DA可帮助患者确认初始治疗偏好,并支持无初始偏好者形成偏好,且79%患者最终偏好与实际接受治疗匹配。
要点
- 网络决策辅助工具可帮助BPH患者确认或形成治疗偏好。
- 使用DA后,51%初始无偏好者能表明偏好,80%有偏好者确认原偏好。
- 79%患者DA使用后的治疗偏好与实际接受治疗匹配。
核心结论
- LUTS/BPH网络决策辅助工具可能帮助患者确认初始治疗偏好,并支持无初始偏好者形成偏好。
研究设计与样本
- 研究纳入2016年7月至2017年1月间使用网络LUTS/BPH决策辅助工具的患者,共126例进行分析。
主要发现
- 34%(43/126)患者未接受过既往治疗,适合生活方式建议或开始药物治疗作为初始治疗。
- 66%(83/126)患者正在使用药物,适合继续药物治疗或接受手术。
- 使用DA前,67例(53%)未决定,59例(47%)有初始治疗偏好。
- 初始未决定者中51%(34/67)在使用DA后能表明偏好;有初始偏好者中80%(47/59)确认原偏好。
- DA使用的7项价值观澄清练习中5项能区分最终治疗偏好;79%患者DA使用后偏好与实际接受治疗匹配。
关键数值与推荐
- DA使用的7项价值观澄清练习中5项对最终治疗偏好有区分度。
- 79%患者DA使用后治疗偏好与实际接受治疗匹配。
临床怎么用
- 临床可考虑使用网络决策辅助工具支持BPH患者的治疗决策,尤其帮助未决定患者形成偏好。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate treatment preferences of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) before and after using a web-based decision aid (DA). PATIENTS AND METHODS: Between July 2016 and January 2017 patients were invited to use a web-based LUTS/BPH DA. Treatment preferences (for lifestyle advices, medication or surgery) before and after DA use and responses on values clarification exercises were extracted from the DA. RESULTS: In total, 126 patients were included in the analysis. Thirty-four percent (43/126) had not received any previous treatment and were eligible for (continuation of) lifestyle advices or to start medication, as initial treatment. The other 66% (83/126) did use medication and were eligible, either for continuing medication or to undergo surgery. Before being exposed to the DA, 67 patients (53%) were undecided and 59 patients (47%) indicated an initial treatment preference. Half of the patients who were initially undecided were able to indicate a preference after DA use (34/67, 51%). Of those with an initial preference, 80% (47/59) confirmed their initial preference after DA use. Five out of 7 values clarification exercises used in the DA were discriminative between final treatment preferences. In 79%, the treatment preferred after DA use matched the received treatment. Overall, healthcare providers were positive about DA feasibility. CONCLUSION: Our findings suggest that a LUTS/BPH DA may help patients to confirm their initial treatment preference and support them in forming a treatment preference if they did not have an initial preference.
引用
- Lamers RED, van der Wijden FC, de Angst IB, et al. Treatment Preferences of Patients With Benign Prostatic Hyperplasia Before and After Using a Web-based Decision Aid. Urology. 2019. PMID: 31899227. doi:10.1016/j.urology.2019.12.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。